Tocilizumab for treatment of antibody mediated rejection in kidney transplant patients

被引：0
|
作者：
Szabo, Eszter [1 ]
Marton, Adrienn [1 ]
Remport, Adam [1 ]
Torok, Szilard [1 ]
Patonai, Attila [1 ]
Piros, Laszlo [1 ]
Fintha, Attila [2 ]
Szijarto, Attila [1 ]
Wagner, Laszlo [1 ]
Cseprekal, Orsolya [1 ]
机构：
[1] Semmelweis Univ, Dept Surg Transplantat & Gastroenterol, Budapest, Hungary
[2] Semmelweis Univ, Dept Pathol & Expt Canc Res, Budapest, Hungary
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
3105
引用
收藏
页码：I2680 / I2680
页数：1
相关论文
共 50 条
  • [1] Tocilizumab for the treatment of chronic antibody mediated rejection in kidney transplant recipients
    Khairallah, Pascale
    Robbins-Juarez, Shelief
    Patel, Shefali
    Shah, Vaqar
    Toma, Katherine
    Fernandez, Hilda
    Dube, Geoffrey K. K.
    King, Kristen
    Mohan, Sumit
    Husain, Syed Ali
    Morris, Heather
    Crew, Russell John
    [J]. CLINICAL TRANSPLANTATION, 2023, 37 (01)
  • [2] TOCILIZUMAB TREATMENT IN DSA POSITIVE ANTIBODY MEDIATED REJECTION AMONG KIDNEY TRANSPLANT RECIPIENTS
    Cseprekal, Orsolya
    Marton, Adrienn
    Molnar, Sara
    Patonai, Attila
    Attila, Fintha
    Micsik, Tamas
    Szilard, Torok
    Wagner, Laszlo
    Kobori, Laszlo
    Remport, Adam
    [J]. TRANSPLANT INTERNATIONAL, 2021, 34 : 292 - 292
  • [3] TOCILIZUMAB TREATMENT IN DSA POSITIVE ANTIBODY MEDIATED REJECTION AMONG KIDNEY TRANSPLANT RECIPIENTS
    Cseprekal, Orsolya
    Marton, Adrienn
    Molnar, Sara
    Patonai, Attila
    Fintha, Attila
    Micsik, Tamas
    Torok, Szilard
    Mathe, Zsolt
    Wagner, Laszlo
    Kobori, Laszlo
    Remport, Adam
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 2074 - 2074
  • [4] Tocilizumab for treatment of chronic active antibody-mediated rejection in kidney transplant recipients
    Boonpheng, Boonphiphop
    De Castro, Iris Camille C.
    Ng, Yue-Harn
    Blosser, Christopher
    Bakthavatsalam, Ramasamy
    Gimferrer, Idoia
    Smith, Kelly
    Leca, Nicolae
    [J]. CLINICAL TRANSPLANTATION, 2023, 37 (05)
  • [5] Use of Tocilizumab in the treatment of chronic active antibody-mediated rejection in pediatric kidney transplant recipients
    Sangermano, Maria
    Negrisolo, Susanna
    Antoniello, Benedetta
    Vadori, Marta
    Cozzi, Emanuele
    Benetti, Elisa
    [J]. HUMAN IMMUNOLOGY, 2024, 85 (05)
  • [6] USE OF TOCILIZUMAB IN THE TREATMENT OF CHRONIC ACTIVE ANTIBODY-MEDIATED REJECTION IN PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS
    Sangermano, Maria
    Negrisolo, Susanna
    Antoniello, Benedetta
    Carraro, Andrea
    Vadori, Marta
    Cuciz, Elisa
    Longo, Germana
    Vidal, Enrico
    Meneghesso, Davide
    Parolin, Mattia
    Cozzi, Emanuele
    Benetti, Elisa
    [J]. PEDIATRIC NEPHROLOGY, 2023, 38 : S52 - S53
  • [7] Efficacy and Safety of Tocilizumab in the Treatment of Acute Active Antibody-mediated Rejection in Kidney Transplant Recipients
    Pottebaum, April A.
    Venkatachalam, Karthikeyan
    Liu, Chang
    Brennan, Daniel C.
    Murad, Haris
    Malone, Andrew F.
    Alhamad, Tarek
    [J]. TRANSPLANTATION DIRECT, 2020, 6 (04): : E543
  • [8] Daratumumab for Treatment of Antibody-Mediated Rejection in a Kidney Transplant Recipient
    Jordan, S. C.
    Vescio, R.
    Toyoda, M.
    Ammerman, N.
    Huang, E.
    Peng, A.
    Sethi, S.
    Najjar, R.
    Lim, K.
    Vo, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 1062 - 1062
  • [9] Tocilizumab Stabilizes Renal Function in Kidney Transplant Recipients with Chronic Active Antibody Mediated Rejection (CAAMR).
    Patel, S.
    Mohan, S.
    Fernandez, H.
    Batal, I.
    Ratner, L.
    Crew, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 326 - 326
  • [10] Tocilizumab in Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients: A Case Series.
    Boonpheng, B.
    Bakthavatsalam, R.
    Blosser, C. D.
    De Castro, I. C.
    Gimferrer, I.
    Ng, Y.
    Leca, N.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 959 - 959
12345